Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome c is a highly conserved small heme protein (approximately 12 kDa) primarily located in the mitochondrial intermembrane space, where it serves as an essential component of the electron transport chain (UniProt: P99999). It functions as a mobile electron carrier, transferring electrons from cytochrome bc1 complex (Complex III) to cytochrome c oxidase (Complex IV), a process vital for ATP synthesis via oxidative phosphorylation (NCBI Gene: 54205). Beyond its bioenergetic role, cytochrome c is a central trigger for the intrinsic pathway of apoptosis; its translocation from the mitochondria to the cytosol leads to the formation of the apoptosome and the activation of the caspase cascade (PubMed: 8887625). In clinical contexts, mutations in the CYCS gene are associated with thrombocytopenia 4, while its dysregulation is a hallmark of cancer and neurodegeneration (StatPearls: NBK554417). Pharmacological modulation of cytochrome c often involves stabilizing its interaction with cardiolipin to preserve mitochondrial integrity, as seen with the investigational drug elamipretide, or inducing its release to promote cell death in oncology (DrugBank: DB12250). Additionally, the release of cytochrome c into the systemic circulation serves as a clinical biomarker for cellular injury and mitochondrial distress in conditions such as myocardial infarction and liver failure (PubMed: 15155835).
Stabilization of mitochondrial membrane association or induction of cytosolic release to trigger the apoptosome.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome c (CYCS) (CYCS).